Skip to content

Subscriptions are live.

Plans

Why is $BSX stock down today?

Boston Scientific Corp. · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS

Why is $BSX down today?

The likely driver

Boston Scientific appoints Joseph M. Fitzgerald Executive Vice President and Chief Operating Officer
Boston Scientific appoints Joseph M. Fitzgerald Executive Vice President and Chief Operating Officer
SEC filing · Oct 7
Price
$45.05
Move today
-1.3%
Volume vs avg
0.0x
Scanner alerts today
2
Flagged in 30 days
96
Market cap
$66.1B
Prev close
$45.65
Avg volume
18.8M

Today’s scanner timeline

  • 10:20 AMUnusual volume (RVOL) alert
  • 7:11 AMBig % mover alert

Unusual-volume alerts often fire before the news is widely reported. This is when our scanner first flagged BSX today.

Earlier scanner activity on BSX

  • Oct 26Unusual volume (RVOL) alert
  • Oct 26Unusual volume (RVOL) alert
  • Oct 26Unusual volume (RVOL) alert
  • Oct 26Unusual volume (RVOL) alert
  • Oct 26Unusual volume (RVOL) alert
  • Oct 23Unusual volume (RVOL) alert
  • Oct 23Unusual volume (RVOL) alert
  • Oct 22Big % mover alert
  • Oct 22Unusual volume (RVOL) alert
  • Oct 22Big % mover alert
  • Oct 22Unusual volume (RVOL) alert
  • Oct 21Big % mover alert

Prior sessions in the last 30 days. A name our scanner keeps flagging is behaving differently from the rest of the market, even on a quiet day.

Free alerts

Get free $BSX alerts the moment volume spikes

Our scanner flagged $BSX 96 times in the last 30 days. Create a free account to track $BSX, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.

Real-time RVOL & momentum alerts Personal watchlist & price alerts
Sign up free with email

No card · 5 premium days · join 800+ traders

Other stocks moving today

Each opens that stock’s own why-is-it-moving page.

Move and volume are based on the latest market data and refresh live on this page. Scanner alerts are our own real-time unusual-volume signals. This is research, not investment advice.